Hsbc Holdings PLC lifted its stake in shares of Globe Life Inc. (NYSE:GL - Free Report) by 6.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 168,473 shares of the company's stock after acquiring an additional 10,889 shares during the quarter. Hsbc Holdings PLC owned 0.20% of Globe Life worth $22,120,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. SouthState Corp bought a new stake in shares of Globe Life during the 1st quarter worth $43,000. Allworth Financial LP lifted its holdings in shares of Globe Life by 22.0% in the first quarter. Allworth Financial LP now owns 571 shares of the company's stock valued at $71,000 after purchasing an additional 103 shares in the last quarter. Versant Capital Management Inc lifted its holdings in shares of Globe Life by 140.2% in the first quarter. Versant Capital Management Inc now owns 586 shares of the company's stock valued at $77,000 after purchasing an additional 342 shares in the last quarter. Brooklyn Investment Group lifted its holdings in shares of Globe Life by 792.7% in the first quarter. Brooklyn Investment Group now owns 732 shares of the company's stock valued at $96,000 after purchasing an additional 650 shares in the last quarter. Finally, Resona Asset Management Co. Ltd. lifted its holdings in shares of Globe Life by 25.4% in the first quarter. Resona Asset Management Co. Ltd. now owns 774 shares of the company's stock valued at $100,000 after purchasing an additional 157 shares in the last quarter. 81.61% of the stock is owned by institutional investors.
Insiders Place Their Bets
In other news, CEO James Matthew Darden sold 33,270 shares of the firm's stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $135.59, for a total value of $4,511,079.30. Following the sale, the chief executive officer directly owned 49,842 shares of the company's stock, valued at approximately $6,758,076.78. This trade represents a 40.03% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Thomas Peter Kalmbach sold 28,952 shares of the firm's stock in a transaction dated Tuesday, July 29th. The shares were sold at an average price of $140.97, for a total value of $4,081,363.44. Following the completion of the sale, the chief financial officer directly owned 30,665 shares in the company, valued at approximately $4,322,845.05. This represents a 48.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 84,722 shares of company stock valued at $11,733,793. 1.51% of the stock is owned by company insiders.
Analyst Upgrades and Downgrades
A number of analysts have recently issued reports on GL shares. BMO Capital Markets restated a "market perform" rating and issued a $149.00 target price (up previously from $114.00) on shares of Globe Life in a report on Wednesday, July 30th. Cfra Research upgraded Globe Life to a "moderate buy" rating in a report on Friday, July 25th. Wall Street Zen upgraded Globe Life from a "hold" rating to a "buy" rating in a report on Friday, May 16th. JPMorgan Chase & Co. increased their price objective on Globe Life from $145.00 to $160.00 and gave the stock an "overweight" rating in a report on Tuesday, July 8th. Finally, Wells Fargo & Company increased their price objective on Globe Life from $144.00 to $150.00 and gave the stock an "overweight" rating in a report on Friday, July 25th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, Globe Life currently has an average rating of "Moderate Buy" and an average target price of $152.45.
Check Out Our Latest Stock Analysis on Globe Life
Globe Life Stock Down 0.3%
Globe Life stock traded down $0.38 during mid-day trading on Thursday, hitting $140.11. 178,846 shares of the company's stock were exchanged, compared to its average volume of 648,637. The company has a current ratio of 0.06, a quick ratio of 0.06 and a debt-to-equity ratio of 0.43. The stock has a market cap of $11.35 billion, a P/E ratio of 11.21 and a beta of 0.56. Globe Life Inc. has a 1-year low of $99.04 and a 1-year high of $144.00. The stock has a 50 day moving average of $130.01 and a two-hundred day moving average of $125.24.
Globe Life (NYSE:GL - Get Free Report) last posted its earnings results on Wednesday, July 23rd. The company reported $3.27 EPS for the quarter, topping the consensus estimate of $3.25 by $0.02. The firm had revenue of $1.48 billion for the quarter, compared to the consensus estimate of $1.50 billion. Globe Life had a net margin of 18.11% and a return on equity of 21.24%. The business's quarterly revenue was up 2.9% on a year-over-year basis. During the same period in the prior year, the business posted $2.97 earnings per share. Globe Life has set its FY 2025 guidance at 14.250-14.650 EPS. As a group, analysts anticipate that Globe Life Inc. will post 13.87 EPS for the current fiscal year.
Globe Life Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, October 3rd will be given a $0.27 dividend. This represents a $1.08 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Friday, October 3rd. Globe Life's dividend payout ratio (DPR) is currently 8.63%.
About Globe Life
(
Free Report)
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Recommended Stories

Before you consider Globe Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.
While Globe Life currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.